Profound Medical (TSE:PRN) Trading Down 9.5%

Profound Medical Corp. (TSE:PRNGet Free Report) shares dropped 9.5% during trading on Friday . The company traded as low as C$11.07 and last traded at C$11.07. Approximately 4,881 shares were traded during trading, a decline of 8% from the average daily volume of 5,295 shares. The stock had previously closed at C$12.23.

Profound Medical Stock Down 9.5 %

The company has a market capitalization of C$270.44 million, a price-to-earnings ratio of -6.29 and a beta of 1.27. The business has a fifty day simple moving average of C$10.78 and a two-hundred day simple moving average of C$11.35. The company has a quick ratio of 14.98, a current ratio of 5.41 and a debt-to-equity ratio of 15.78.

Profound Medical (TSE:PRNGet Free Report) last posted its earnings results on Thursday, May 9th. The company reported C($0.35) EPS for the quarter, topping the consensus estimate of C($0.41) by C$0.06. The company had revenue of C$2.58 million for the quarter, compared to the consensus estimate of C$3.24 million. Equities analysts expect that Profound Medical Corp. will post -1.9000001 EPS for the current year.

Profound Medical Company Profile

(Get Free Report)

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.

See Also

Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.